Topic Highlight
Copyright ©The Author(s) 2015.
World J Gastrointest Oncol. Nov 15, 2015; 7(11): 271-284
Published online Nov 15, 2015. doi: 10.4251/wjgo.v7.i11.271
Table 1 Autophagy-related genes in colorectal cancer
Gene/proteinExpression level in colorectal cancer
LC3/LC3-IIHigher expression, especially in advanced stages[20]
Higher expression associated with aggressiveness[71]
Higher perinuclear expression associated with positive prognosis[77]
Higher levels in DLD-1 and SW480 CRC lines treated with autophagy inhibitors[72]
Higher levels in CRC cell lines treated with 5-FU[73]
Higher levels in CRC cell lines treated with 5-FU and radiotreated[74]
Lower levels associated with good outcome and treatment response[75,76]
Negative expression associated with poor clinical outcome and survival[87]
BECN1/Higher expression, negatively linked to metastasis[82]
Beclin-1Higher expression associated with favorable outcome[83]
Higher expression associated with longer survival in patients treated with 5-FU[84]
Higher expression associated with a worse survival in patients treated with 5-FU[85]
Higher expression associated with metastasis and worse prognosis[86]
Lower levels associated with increased survival in advanced CRC patients treated with cetuximab[75,76]
Lower levels associated with poor clinical outcome and survival[87]
Lower levels associated with a good response after chemoradiation in patients with rectal cancer[88]
ATG5Higher levels associated with lymphovascular invasion[92]
Lower levels[91]
Lower expression associated with poor clinical outcome survival[87]
Lower expression enhanced sensitivity to oxaliplatin[93]
ATG10Higher expression associated with tumor lymph node metastasis and poor survival[95]
ATG16L1ATG16L1T300A polymorphism improved overall survival in human CRC patients[116]
BCL2/Bcl-2Higher levels associated with migration and invasion[105]
Higher levels associated with resistance to paclitaxel[106]
Bif-1Lower levels[109]